September 2026
The global insulin market size is evaluated at USD 119.25 billion in 2026 and is projected to hit around USD 119.25 billion by 2035, with a CAGR of 13.43%.
September 2026
The global insulin pump market size is estimated to hit around USD 15.59 billion by 2035 increasing from USD 7.71 billion in 2026, with a CAGR of 8.15%.
September 2026
The global insulin drugs and delivery devices market size is evaluated at USD 27.47 billion in 2026 and is predicted to hit around USD 52.72 billion by 2035, growing at a CAGR of 7.52%.
September 2026
The insulin delivery devices market size reached USD 22.50 billion in 2026, with leading insulin delivery devices market companies including Novo Nordisk A/S, Wockhardt Ltd., Medtronic.
September 2026
The global non-injectable insulin market size is expected to increase from USD 2.13 billion in 2026 and is expected to hit around USD 5.63 billion by 2034 at a CAGR of 12.99%.
September 2026
The U.S. insulin pump market generated USD 2.48 billion in 2026, with prominent U.S. insulin pump market companies including Medzer, Cequr SA, Medtronic.
September 2026
The global tubeless insulin pump market size was evaluated at USD 3.48 billion in 2026 and is projected to reach around USD 13.65 billion by 2034, with a CAGR of 18.74%.
September 2026
The global implantable insulin pumps market size is evaluated at USD 5.79 billion in 2025 and is predicted to hit around USD 15.54 billion by 2035, growing at a CAGR of 10.38%.
April 2026
The global smart insulin pens market size was exhibited at USD 183.25 million in 2025 and is projected to hit around USD 756.34 million by 2035 with a CAGR of 15.23%.